As cannabis legalization and psychedelic policy reforms continue to evolve across the United States, the researchers say ...

In a surprisingly strong rejection of the first psychedelic therapy to come before the Food and Drug Administration, a scientific advisory panel on Tuesday overwhelmingly voted against the use of MDMA ...

Ducharme is a contributor to TIME. Ducharme is a contributor to TIME. For a while, MDMA looked poised to make history. After decades of advocacy from impassioned supporters, the party drug best known ...

June 4 (Reuters) - Advisers to the U.S. Food and Drug Administration on Tuesday voted against a therapy based on the mind-altering drug MDMA for patients with post-traumatic stress disorder, marking a ...

The US Food and Drug Administration has declined to approve an application for the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news ...

When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...

May 31 (Reuters) - The U.S. health regulator's staff said on Friday data on the psychedelic drug MDMA for post-traumatic stress disorder was difficult to interpret, and raised new safety concerns ...